VEEVA SYSTEMS INC CLASS A

NYSE: VEEV (Veeva Systems Inc.)

Kemas kini terakhir: 09 Apr, 7:07AM

209.39

-5.35 (-2.49%)

Penutupan Terdahulu 214.74
Buka 220.45
Jumlah Dagangan 1,110,886
Purata Dagangan (3B) 1,228,516
Modal Pasaran 34,066,915,328
Harga / Pendapatan (P/E TTM) 48.58
Harga / Pendapatan (P/E Ke hadapan) 31.85
Harga / Jualan (P/S) 14.02
Harga / Buku (P/B) 6.51
Julat 52 Minggu
170.25 (-18%) — 258.93 (23%)
Tarikh Pendapatan 28 May 2025 - 2 Jun 2025
Margin Keuntungan 26.00%
Margin Operasi (TTM) 26.14%
EPS Cair (TTM) 4.31
Pertumbuhan Hasil Suku Tahunan (YOY) 14.30%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 32.70%
Jumlah Hutang/Ekuiti (D/E MRQ) 1.30%
Nisbah Semasa (MRQ) 4.51
Aliran Tunai Operasi (OCF TTM) 1.09 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 942.78 M
Pulangan Atas Aset (ROA TTM) 6.57%
Pulangan Atas Ekuiti (ROE TTM) 13.63%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Health Information Services (US) Menurun Bercampur
Health Information Services (Global) Menurun Bercampur
Stok Veeva Systems Inc. Menaik Menaik

AISkor Stockmoo

0.8
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga 1.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal 0.5
Purata 0.75

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
VEEV 34 B - 48.58 6.51
SOLV 13 B - 33.42 3.74
DOCS 10 B - 45.96 8.90
PHR 1 B - - 5.41
EVH 846 M - - 1.15
WEAV 721 M - - 9.97

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Sektor Healthcare
Industri Health Information Services
Gaya Pelaburan Mid Growth
% Dimiliki oleh Orang Dalam 8.58%
% Dimiliki oleh Institusi 86.68%
359.50359.50316.00316.00272.50272.50229.00229.00185.50185.50Harga Sasaran MedianQ2 '20Q2 '20Q3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
170.25 (-18%) — 258.93 (23%)
Julat Harga Sasaran
201.00 (-4%) — 285.00 (36%)
Tinggi 285.00 (Baird, 36.11%) Beli
Median 250.00 (19.39%)
Rendah 201.00 (Morgan Stanley, -4.01%) Jual
Purata 250.22 (19.50%)
Jumlah 5 Beli, 3 Pegang, 1 Jual
Harga Purata @ Panggilan 232.65
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Piper Sandler 23 Apr 2025 255.00 (21.78%) Beli 220.53
Keybanc 16 Apr 2025 250.00 (19.39%) Beli 220.66
JP Morgan 20 Mar 2025 249.00 (18.92%) Pegang 235.85
Baird 06 Mar 2025 285.00 (36.11%) Beli 236.14
Morgan Stanley 06 Mar 2025 201.00 (-4.01%) Jual 236.14
Needham 06 Mar 2025 270.00 (28.95%) Beli 236.14
Scotiabank 06 Mar 2025 245.00 (17.01%) Pegang 236.14
Stephens & Co. 06 Mar 2025 280.00 (33.72%) Beli 236.14
Truist Securities 06 Mar 2025 217.00 (3.63%) Pegang 236.14

Tiada data dalam julat masa ini.

245.20245.20239.97239.97234.75234.75229.53229.53224.31224.31May 14May 14May 15May 15May 16May 16May 19May 19May 20May 20May 21May 21May 22May 22May 23May 23

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
4.0004.0003.0003.0002.0002.0001.0001.0000.0000.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda